CytomX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.
CEOSean A. McCarthy
CEOSean A. McCarthy
Employees121
Employees121
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2010
Founded2010
Employees121
Employees121
CTMX Key Statistics
Market cap693.84M
Market cap693.84M
Price-Earnings ratio9.71
Price-Earnings ratio9.71
Dividend yield—
Dividend yield—
Average volume1.61M
Average volume1.61M
High today$4.12
High today$4.12
Low today$3.98
Low today$3.98
Open price$4.06
Open price$4.06
Volume107.10K
Volume107.10K
52 Week high$4.62
52 Week high$4.62
52 Week low$0.40
52 Week low$0.40
Stock Snapshot
CytomX(CTMX) stock is priced at $4.10, giving the company a market capitalization of 693.84M. It carries a P/E multiple of 9.71.
On 2025-12-12, CytomX(CTMX) stock moved within a range of $3.98 to $4.12. With shares now at $4.10, the stock is trading +2.9% above its intraday low and -0.6% below the session's peak.
Trading volume for CytomX(CTMX) stock has reached 107.1K, versus its average volume of 1.61M.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $4.62 and a low of $0.40.
Over the past 52 weeks, CytomX(CTMX) stock has traded between a high of $4.62 and a low of $0.40.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.